Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women

NCT01343004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2463

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Postmenopausal Osteoporosis

Interventions

DRUG: Placebo
DRUG: BA058 80 mcg
DRUG: teriparatide

Sponsor

Radius Health, Inc.